Tekturna Lawsuit

Tekturna and Tekturna HCT are oral hypertension prescriptions that are used to reduce high blood pressure. A recent clinical study conducted by Novartis, the manufacturer of Tekturna, was terminated early. Researchers in the ALTITUDE study of the drug observed an increased number of serious Tekturna side effects in the study’s participants.

Tekturna ALTITUDE Study

The ALTITUDE study was originally conducted to test whether Tekturna would provide additional benefits for patients diagnosed with Type-2 diabetes and hypertension as these patients were at an increased risk of cardiovascular or renal events.

Upon review of preliminary results, an independent safety committee discovered an increased rate of non-fatal stroke, renal problems, hyperkalemia and low blood pressure. In December 2011, Novartis immediately terminated the study and ceased promotion of Tekturna and all other drugs that contained the active ingredient aliskiren. Specifically, they recommended that patients should not use Tekturna in combination with other common hypertension medications.

Tekturna and Kidney Damage

Especially for patients with existing kidney problems, the ALTITUDE study showed a significant increase in the risk of kidney damage. Tekturna may also reduce the kidneys’ ability to eliminate excess potassium from the bloodstream, causing high levels of potassium. A high potassium level in the bloodstream is a potentially life-threatening condition known as hyperkalemia.

The earliest symptoms of hyperkalemia are mild, including:

  • Nausea
  • Muscle weakness
  • Fatigue
  • Heart palpitations

Hyperkalemia symptoms can escalate quickly, however, and often result in severe irregular heartbeat and sudden death. About 67 percent of people with untreated hyperkalemia will die from the condition.

Increased Risk of Stroke with Tekturna Use

One of the major reasons why the ALTITUDE study was terminated early was the increased risk of non-fatal stroke. While non-fatal strokes do not result in wrongful death, they can result in severe disability. Disabilities from non-fatal strokes often require both costly medical treatment and lifelong assistance.

Possible side effects of Tekturna and Tekturna HCT include, but are not limited to, the following:

  • Cardiovascular events
  • Irregular heartbeat
  • Significant increase in potassium in the bloodstream (hyperkalemia)
  • Renal injury
  • Low blood pressure

Tekturna Lawsuit Attorneys

If you or a loved one has suffered from kidney damage, non-fatal strokes, high potassium levels or low blood pressure after taking Tekturna, you may be eligible to file a Tekturna side effect lawsuit to recover your losses.

Tekturna side effect lawsuits may be filed in order to help victims of this dangerous drug recover damages from medical bills, pain and suffering, emotional trauma and other losses related to the adverse side effects.

For more information on the legal rights which may be available to Tekturna side effects victims, complete the Free Case Evaluation form on this page to contact the dangerous drug lawyers at The Eichholz Law Firm.